Literature DB >> 30039169

Assessment of Pragmatism in Recently Published Randomized Clinical Trials.

Perrine Janiaud1, Rafael Dal-Ré2, John P A Ioannidis3.   

Abstract

Mesh：

Year:  2018        PMID： 30039169      PMCID： PMC6142963          DOI： 10.1001/jamainternmed.2018.3321

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

1.  The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.

Authors:  Kalipso Chalkidou; Sean Tunis; Danielle Whicher; Robert Fowler; Merrick Zwarenstein
Journal:  Clin Trials       Date:  2012-07-02       Impact factor: 2.486

2.  The PRECIS-2 tool: designing trials that are fit for purpose.

Authors:  Kirsty Loudon; Shaun Treweek; Frank Sullivan; Peter Donnan; Kevin E Thorpe; Merrick Zwarenstein
Journal:  BMJ       Date:  2015-05-08

3.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Authors:  Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas G Altman; Sean Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
Journal:  J Clin Epidemiol       Date:  2009-05       Impact factor: 6.437

4.  Real-World Evidence - What Is It and What Can It Tell Us?

Authors:  Rachel E Sherman; Steven A Anderson; Gerald J Dal Pan; Gerry W Gray; Thomas Gross; Nina L Hunter; Lisa LaVange; Danica Marinac-Dabic; Peter W Marks; Melissa A Robb; Jeffrey Shuren; Robert Temple; Janet Woodcock; Lilly Q Yue; Robert M Califf
Journal:  N Engl J Med       Date:  2016-12-08       Impact factor: 91.245

5.  Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers.

Authors:  Ruijun Chen; Nihar R Desai; Joseph S Ross; Weiwei Zhang; Katherine H Chau; Brian Wayda; Karthik Murugiah; Daniel Y Lu; Amit Mittal; Harlan M Krumholz
Journal:  BMJ       Date:  2016-02-17

6.  Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?

Authors:  Rafael Dal-Ré; Perrine Janiaud; John P A Ioannidis
Journal:  BMC Med       Date:  2018-04-03       Impact factor: 8.775
  6 in total
  10 in total

1.  The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.

Authors:  Rafael Dal-Ré
Journal:  Eur J Clin Pharmacol       Date:  2020-10-26       Impact factor: 2.953

2.  Practical steps to identifying the research risk of pragmatic trials.

Authors:  Scott Yh Kim; Jonathan Kimmelman
Journal:  Clin Trials       Date:  2022-03-29       Impact factor: 2.599

Review 3.  A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.

Authors:  Stuart G Nicholls; Kelly Carroll; Spencer Phillips Hey; Merrick Zwarenstein; Jennifer Zhe Zhang; Hayden P Nix; Jamie C Brehaut; Joanne E McKenzie; Steve McDonald; Charles Weijer; Dean A Fergusson; Monica Taljaard
Journal:  J Clin Epidemiol       Date:  2021-03-28       Impact factor: 6.437

Review 4.  Leveraging Data Science for a Personalized Haemodialysis.

Authors:  Miguel Hueso; Lluís de Haro; Jordi Calabia; Rafael Dal-Ré; Cristian Tebé; Karina Gibert; Josep M Cruzado; Alfredo Vellido
Journal:  Kidney Dis (Basel)       Date:  2020-05-25

5.  Perceived helpfulness of treatment for posttraumatic stress disorder: Findings from the World Mental Health Surveys.

Authors:  Dan J Stein; Meredith G Harris; Daniel V Vigo; Wai Tat Chiu; Nancy Sampson; Jordi Alonso; Yasmin Altwaijri; Brendan Bunting; José Miguel Caldas-de-Almeida; Alfredo Cía; Marius Ciutan; Louisa Degenhardt; Oye Gureje; Aimee Karam; Elie G Karam; Sing Lee; Maria Elena Medina-Mora; Zeina Mneimneh; Fernando Navarro-Mateu; José Posada-Villa; Charlene Rapsey; Yolanda Torres; Maria Carmen Viana; Yuval Ziv; Ronald C Kessler
Journal:  Depress Anxiety       Date:  2020-07-15       Impact factor: 8.128

6.  Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.

Authors:  Kevin J Anstrom; Imre Noth; Kevin R Flaherty; Rex H Edwards; Joan Albright; Amanda Baucom; Maria Brooks; Allan B Clark; Emily S Clausen; Michael T Durheim; Dong-Yun Kim; Jerry Kirchner; Justin M Oldham; Laurie D Snyder; Andrew M Wilson; Stephen R Wisniewski; Eric Yow; Fernando J Martinez
Journal:  Respir Res       Date:  2020-03-12

7.  A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.

Authors:  Luigi F Meneghini; Sean D Sullivan; Gerry Oster; Robert Busch; Anna M G Cali; Arnaud Dauchy; Jasvinder Gill; Timothy S Bailey
Journal:  Diabetes Obes Metab       Date:  2020-09-03       Impact factor: 6.577

Review 8.  Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis.

Authors:  Shelley Vanderhout; Dean A Fergusson; Jonathan A Cook; Monica Taljaard
Journal:  PLoS Med       Date:  2022-02-08       Impact factor: 11.069

9.  Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute.

Authors:  Wynne E Norton; Merrick Zwarenstein; Susan Czajkowski; Elisabeth Kato; Ann O'Mara; Nonniekaye Shelburne; David A Chambers; Kirsty Loudon
Journal:  Trials       Date:  2019-12-27       Impact factor: 2.279

10.  Perceived helpfulness of treatment for generalized anxiety disorder: a World Mental Health Surveys report.

Authors:  Dan J Stein; Alan E Kazdin; Ayelet Meron Ruscio; Wai Tat Chiu; Nancy A Sampson; Hannah N Ziobrowski; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Yasmin Altwaijri; Ronny Bruffaerts; Brendan Bunting; Giovanni de Girolamo; Peter de Jonge; Louisa Degenhardt; Oye Gureje; Josep Maria Haro; Meredith G Harris; Aimee Karam; Elie G Karam; Viviane Kovess-Masfety; Sing Lee; Maria Elena Medina-Mora; Jacek Moskalewicz; Fernando Navarro-Mateu; Daisuke Nishi; José Posada-Villa; Kate M Scott; Maria Carmen Viana; Daniel V Vigo; Miguel Xavier; Zahari Zarkov; Ronald C Kessler
Journal:  BMC Psychiatry       Date:  2021-08-09       Impact factor: 3.630
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.